Original Research
Published on 09 Feb 2026
Tumour microenvironment and HER2-low status dictate response and resistance to anthracycline-taxane chemotherapy in premenopausal TNBC: a retrospective multicohort study
in Pharmacology of Anti-Cancer Drugs
- 125 views